Vaccines for Biodefense and Emerging and Neglected Diseases

Descargar/Download

Contenidos del Libro:

Part I: Biothreats and Emerging Infectious Diseases
1.- Agents of Emerging Infectious Diseases
2.- Bacterial Biothreat Agents
3.-Viral Biothreat Agents

Part II: Fundamental Aspects of Vaccinology
4.- Vaccine Development Pathway
5.-Immunology of Vaccines: Consideration of the Neonate as a Target for Vaccination
6.- Molecular Approaches to Bacterial Vaccines
7.- Viral Vectors
8.- DNA Vaccines for Biodefense and Emerging and Neglected Infectious Diseases
9.- Vaccine Adjuvants
10.- Preclinical Vaccine Development: Implementing the Food and Drug Administration’s Good Laboratory Practices in a Biocontainment Environment — A University BSL3/BSL4 Laboratory Perspective
11.- Manufacturing Vaccines for an Emerging Viral Infection – Specific Issues Associated with the Development of a Prototype SARS Vaccine
12.- Clinical Trials of Vaccines for Biodefense and Emerging and Neglected Diseases
13.- The US Food and Drug Administration Pre-IND and IND Process for Vaccines
14.- U.S. Regulatory Issues Related to Vaccines against Emerging Infectious Diseases
15.- Vaccine Safety
16.- Special Issues around Veterinary Vaccines
17.- Misinformation about Vaccines
18.- Vaccines for Military Application

Part III: Viral Vaccines
19.- Dengue
20.- Ebola and Marburg
21.- Alphaviral Encephalitides
22.- Foot-and-Mouth Disease
23.- Hantavirus
24.- Hepatitis C
25.- Human Immunodeficiency Virus
26.- Human Papillomavirus
27.- Influenza
28.- Japanese Encephalitis
29.- Junin (Argentine Hemorrhagic Fever)
30.- Measles
31.- Hendra and Nipah
32.- O’nyong-nyong and Chikungunya
33.- Rabies
34.- Ross River Virus: Epidemic Polyarthritis
35.- Rotavirus
36.- SARS
37.- Smallpox
38.- Tick-Borne Encephalitis
39.- West Nile
40.- Yellow Fever

Part IV: Bacterial Vaccines
41.- Anthrax
42.- Brucellosis
43.- Burkholderia mallei and Burkholderia pseudomallei
44.- Chlamydia
45.- Cholera
46.- Botulinum Toxin
47.- Ehrlichia
48.- Extraintestinal Pathogenic Escherichia coli
49.- Gonorrhea
50.- Helicobacter pylori
51.- Intestinal Pathogenic Escherichia coli
52.- Lyme Disease
53.- Neisseria meningitidis
54.- Plague
55.- Ricin: A Type II Ribosome-Inactivating Protein
56.- Rickettsia
57.- Typhoid Fever
58.- Shigellosis
59.- Syphilis
60.- Mycobacterium tuberculosis
61.- Francisella tularensis

Part V: Parasitic Vaccines
62.- African Trypanosomiasis
63.- Leishmaniasis
64.- Leptospirosis
65.- Malaria
66.- Hookworm Infection
67.- Onchocerciasis
68.- Schistosomiasis
69.- American Trypanosomiasis